To read the full story, subscribe or sign in.

South Korea aiming to be major player in global biosimilars market

June 6, 2018

HONG KONG – South Korea is striving to be a global hub for biosimilars, as domestic biopharma firms such as Celltrion Inc., Samsung Bioepis Co. Ltd. and LG Chem Ltd. are all spearheading their biosimilars development.

BioWorld Asia

Free access to BioWorld coronavirus articles

BioWorld

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

Today's news in brief

BioWorld

BioWorld briefs for March 8.

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for March 8.

Coronavirus vaccine/therapeutics illustration

Tonix looks to the past for the future of COVID-19 vaccines and testing

BioWorld MedTech

Tonix Pharmaceuticals Holding Corp. is looking to lessons from tuberculosis and smallpox to guide its future in infectious diseases. The company is developing an...

Braincool wins breakthrough nod for system to prevent painful chemo side effect

BioWorld MedTech

Braincool AB has scored a breakthrough device designation from the U.S. FDA for its Cooral system, a medical cooling technology for therapeutic hypothermia and...